KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Depreciation and Depletion (2016 - 2026)

Abbott Laboratories' Depreciation and Depletion history spans 18 years, with the latest figure at $381.0 million for Q1 2026.

  • On a quarterly basis, Depreciation and Depletion rose 13.39% to $381.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 billion, a 10.13% increase, with the full-year FY2025 number at $1.4 billion, up 7.01% from a year prior.
  • Depreciation and Depletion hit $381.0 million in Q1 2026 for Abbott Laboratories, up from $370.0 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for ABT hit a ceiling of $381.0 million in Q1 2026 and a floor of $302.0 million in Q2 2023.
  • Historically, Depreciation and Depletion has averaged $334.5 million across 5 years, with a median of $332.0 million in 2023.
  • Biggest five-year swings in Depreciation and Depletion: decreased 26.82% in 2022 and later increased 13.39% in 2026.
  • Tracing ABT's Depreciation and Depletion over 5 years: stood at $311.0 million in 2022, then rose by 6.75% to $332.0 million in 2023, then grew by 3.01% to $342.0 million in 2024, then rose by 8.19% to $370.0 million in 2025, then increased by 2.97% to $381.0 million in 2026.
  • Business Quant data shows Depreciation and Depletion for ABT at $381.0 million in Q1 2026, $370.0 million in Q4 2025, and $371.0 million in Q3 2025.